Phenotypic and functional characteristics of in vivo-induced interleukin-12-activated killer cells

This publication has 11 references indexed in Scilit:

• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo
  International Immunology, 1994
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
  The Journal of Experimental Medicine, 1993
• Development of T _H 1 CD4 ⁺ T Cells Through IL-12 Produced by Listeria -Induced Macrophages
  Science, 1993
• Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
  The Journal of Experimental Medicine, 1993
• Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
  The Journal of Experimental Medicine, 1992
• Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
  The Journal of Experimental Medicine, 1992
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
  The Journal of Experimental Medicine, 1989
• Administration of slowly released recombinant interleukin 2 Augmentation of the efficacy of adoptive immunotherapy with lymphokine-activated killer (LAK) cells
  Journal of Immunological Methods, 1986
• Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes
  Cellular Immunology, 1986
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982